FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3037130386> ?p ?o ?g. }

• W3037130386 endingPage "e000527" @default.
• W3037130386 startingPage "e000527" @default.
• W3037130386 abstract "Background Despite prolonged tumor response to immune checkpoint inhibitors (ICIs) for a subset of patients with advanced non-small cell lung cancer (NSCLC), a secondary resistance will occur for a majority of these patients. The understanding of late progression mechanisms with ICIs is important to improve future treatment strategies. Methods We performed whole-exome sequencing (WES) on circulating tumor DNA and compared molecular profiles between the beginning of ICI treatment and tumor progression in patients with advanced NSCLC treated with ICIs and who had initial and prolonged tumor response with secondary progression, after at least 6 months of treatment. Results We identified eight patients who experienced initial and durable tumor response, and secondary tumor progression after 6 months of treatment, with available paired blood samples (diagnosis and progression). All had lung adenocarcinoma, three had programmed-death ligand-1 expression ≥50% in immunohistochemistry and all presented low blood tumor mutational burden (bTMB). Seven patients received nivolumab in second-line or more, and one received pembrolizumab as first-line treatment. WES at progression showed clonal selection with molecular alterations of Wnt pathway-related genes, increase of copy number aberrations in cancer-related genes and loss of tumor-suppressor genes (such as PTEN ) or of genes associated with immune response (such as B2M ). No difference in term of bTMB was observed at progression. Conclusions This is the first study describing putative molecular mechanisms associated with late progression under ICI in lung cancer. Studies on treatment strategies adapted to these mechanisms are needed." @default.
• W3037130386 created "2020-07-02" @default.
• W3037130386 creator A5005050372 @default.
• W3037130386 creator A5019264128 @default.
• W3037130386 creator A5031066819 @default.
• W3037130386 creator A5040326773 @default.
• W3037130386 creator A5057230592 @default.
• W3037130386 creator A5061864491 @default.
• W3037130386 creator A5069636706 @default.
• W3037130386 creator A5070179654 @default.
• W3037130386 creator A5077224541 @default.
• W3037130386 creator A5080839939 @default.
• W3037130386 creator A5083457325 @default.
• W3037130386 creator A5088907508 @default.
• W3037130386 creator A5089759719 @default.
• W3037130386 date "2020-06-01" @default.
• W3037130386 modified "2023-10-18" @default.
• W3037130386 title "Sequential ctDNA whole-exome sequencing in advanced lung adenocarcinoma with initial durable tumor response on immune checkpoint inhibitor and late progression" @default.
• W3037130386 cites W1498931318 @default.
• W3037130386 cites W2054424062 @default.
• W3037130386 cites W2104347254 @default.
• W3037130386 cites W2121531763 @default.
• W3037130386 cites W2141645337 @default.
• W3037130386 cites W2156353875 @default.
• W3037130386 cites W2198093519 @default.
• W3037130386 cites W2201379305 @default.
• W3037130386 cites W2214552500 @default.
• W3037130386 cites W2257956371 @default.
• W3037130386 cites W2465860350 @default.
• W3037130386 cites W2527905628 @default.
• W3037130386 cites W2567564314 @default.
• W3037130386 cites W2591493010 @default.
• W3037130386 cites W2593030814 @default.
• W3037130386 cites W2607288266 @default.
• W3037130386 cites W2763186529 @default.
• W3037130386 cites W2765417948 @default.
• W3037130386 cites W2769006626 @default.
• W3037130386 cites W2796582438 @default.
• W3037130386 cites W2797675588 @default.
• W3037130386 cites W2805354595 @default.
• W3037130386 cites W2886963239 @default.
• W3037130386 cites W2892640821 @default.
• W3037130386 cites W2894066036 @default.
• W3037130386 cites W2900082702 @default.
• W3037130386 cites W2902771169 @default.
• W3037130386 cites W2946386783 @default.
• W3037130386 cites W2975736787 @default.
• W3037130386 cites W3002662929 @default.
• W3037130386 cites W4249830075 @default.
• W3037130386 doi "https://doi.org/10.1136/jitc-2020-000527" @default.
• W3037130386 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7319709" @default.
• W3037130386 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32581058" @default.
• W3037130386 hasPublicationYear "2020" @default.
• W3037130386 type Work @default.
• W3037130386 sameAs 3037130386 @default.
• W3037130386 citedByCount "22" @default.
• W3037130386 countsByYear W30371303862021 @default.
• W3037130386 countsByYear W30371303862022 @default.
• W3037130386 countsByYear W30371303862023 @default.
• W3037130386 crossrefType "journal-article" @default.
• W3037130386 hasAuthorship W3037130386A5005050372 @default.
• W3037130386 hasAuthorship W3037130386A5019264128 @default.
• W3037130386 hasAuthorship W3037130386A5031066819 @default.
• W3037130386 hasAuthorship W3037130386A5040326773 @default.
• W3037130386 hasAuthorship W3037130386A5057230592 @default.
• W3037130386 hasAuthorship W3037130386A5061864491 @default.
• W3037130386 hasAuthorship W3037130386A5069636706 @default.
• W3037130386 hasAuthorship W3037130386A5070179654 @default.
• W3037130386 hasAuthorship W3037130386A5077224541 @default.
• W3037130386 hasAuthorship W3037130386A5080839939 @default.
• W3037130386 hasAuthorship W3037130386A5083457325 @default.
• W3037130386 hasAuthorship W3037130386A5088907508 @default.
• W3037130386 hasAuthorship W3037130386A5089759719 @default.
• W3037130386 hasBestOaLocation W30371303861 @default.
• W3037130386 hasConcept C104317684 @default.
• W3037130386 hasConcept C10590036 @default.
• W3037130386 hasConcept C121608353 @default.
• W3037130386 hasConcept C126322002 @default.
• W3037130386 hasConcept C143998085 @default.
• W3037130386 hasConcept C16671776 @default.
• W3037130386 hasConcept C190283241 @default.
• W3037130386 hasConcept C2776256026 @default.
• W3037130386 hasConcept C2777609662 @default.
• W3037130386 hasConcept C2777701055 @default.
• W3037130386 hasConcept C2779256057 @default.
• W3037130386 hasConcept C2780030458 @default.
• W3037130386 hasConcept C2780057760 @default.
• W3037130386 hasConcept C2780265364 @default.
• W3037130386 hasConcept C2780851360 @default.
• W3037130386 hasConcept C2781053074 @default.
• W3037130386 hasConcept C2781182431 @default.
• W3037130386 hasConcept C501734568 @default.
• W3037130386 hasConcept C502942594 @default.
• W3037130386 hasConcept C55493867 @default.
• W3037130386 hasConcept C71924100 @default.
• W3037130386 hasConcept C86554907 @default.
• W3037130386 hasConcept C86803240 @default.
• W3037130386 hasConceptScore W3037130386C104317684 @default.

• next